OTCMKTS:CPBLF ALS (CPBLF) Stock Price, News & Analysis $9.70 0.00 (0.00%) As of 02/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort Interest About ALS Stock (OTCMKTS:CPBLF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ALS alerts:Sign Up Key Stats Today's Range$9.70▼$9.7050-Day Range$9.42▼$9.7052-Week Range$9.42▼$10.36VolumeN/AAverage Volume460 shsMarket CapitalizationN/AP/E Ratio33.56Dividend Yield4.02%Price TargetN/AConsensus RatingN/A Company OverviewALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.Read More… Receive CPBLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALS and its competitors with MarketBeat's FREE daily newsletter. Email Address CPBLF Stock News HeadlinesALS Limited Announces Cessation of Performance RightsJanuary 14, 2025 | tipranks.comAmylyx (AMLX) Stock Spikes 13% as FDA Resumes Discussion of ALS DrugJuly 5, 2022 | investorplace.comSee More Headlines CPBLF Stock Analysis - Frequently Asked Questions How have CPBLF shares performed this year? ALS's stock was trading at $9.5850 at the start of the year. Since then, CPBLF shares have increased by 1.2% and is now trading at $9.70. View the best growth stocks for 2025 here. How do I buy shares of ALS? Shares of CPBLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Consulting Services Sub-IndustryN/A Current SymbolOTCMKTS:CPBLF CUSIPN/A CIKN/A Webwww.alsglobal.com Phone(173) 367-7900FaxN/AEmployees19,565Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio33.56 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (OTCMKTS:CPBLF) was last updated on 2/4/2025 by MarketBeat.com Staff From Our Partners“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredTexas' Radical New Anti-Dollar LawTexas has passed a surprise "anti-dollar" bill... and it's now embracing a new currency that the federal gover...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALS Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ALS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.